Literature DB >> 16183191

The effect of HIV-1 Gag myristoylation on membrane binding.

Paxton Provitera1, Raafat El-Maghrabi, S Scarlata.   

Abstract

During the viral life cycle, an HIV protein, Gag, assembles at the host membrane, specifically at lipid raft regions, at very high concentrations leading to viral particle budding. Gag is post-translationally modified with an N-terminal myristate group which is thought to target Gag to lipid rafts thus aiding in assembly. Here we have analyzed the membrane binding of myristoylated HIV-1 Gag and a non-myristoylated form of HIV-1 Gag to various membrane models. After assessing the extent of myristoylation by HPLC and radiometric assays, we compared membrane binding using fluorescence methods. We found that myristoylated Gag shows a greater than twofold increase in binding affinity to model rafts. A structural model to explain these results is presented.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16183191     DOI: 10.1016/j.bpc.2005.08.008

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  15 in total

1.  Electrostatic interactions and binding orientation of HIV-1 matrix studied by neutron reflectivity.

Authors:  Hirsh Nanda; Siddhartha A K Datta; Frank Heinrich; Mathias Lösche; Alan Rein; Susan Krueger; Joseph E Curtis
Journal:  Biophys J       Date:  2010-10-20       Impact factor: 4.033

2.  Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles.

Authors:  Bao-Zhong Wang; Weimin Liu; Sang-Moo Kang; Munir Alam; Chunzi Huang; Ling Ye; Yuliang Sun; Yingying Li; Denise L Kothe; Peter Pushko; Terje Dokland; Barton F Haynes; Gale Smith; Beatrice H Hahn; Richard W Compans
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

3.  A myristoyl/phosphoserine switch controls cAMP-dependent protein kinase association to membranes.

Authors:  Ece C Gaffarogullari; Larry R Masterson; Emily E Metcalfe; Nathaniel J Traaseth; Erica Balatri; Musa M Musa; Daniel Mullen; Mark D Distefano; Gianluigi Veglia
Journal:  J Mol Biol       Date:  2011-06-29       Impact factor: 5.469

Review 4.  The chemical toolbox for monitoring protein fatty acylation and prenylation.

Authors:  Rami N Hannoush; Jinglucy Sun
Journal:  Nat Chem Biol       Date:  2010-07       Impact factor: 15.040

Review 5.  HIV-1 Gag as an Antiviral Target: Development of Assembly and Maturation Inhibitors.

Authors:  Paul Spearman
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

6.  Electrostatic interactions drive membrane association of the human immunodeficiency virus type 1 Gag MA domain.

Authors:  Amanda K Dalton; Danso Ako-Adjei; Paul S Murray; Diana Murray; Volker M Vogt
Journal:  J Virol       Date:  2007-03-28       Impact factor: 5.103

7.  A fluorescence-based assay for N-myristoyltransferase activity.

Authors:  Victor Goncalves; James A Brannigan; Emmanuelle Thinon; Tayo O Olaleye; Remigiusz Serwa; Salvatore Lanzarone; Anthony J Wilkinson; Edward W Tate; Robin J Leatherbarrow
Journal:  Anal Biochem       Date:  2011-10-14       Impact factor: 3.365

Review 8.  Intercellular Communication in the Nervous System Goes Viral.

Authors:  Michael P Hantak; Jenifer Einstein; Rachel B Kearns; Jason D Shepherd
Journal:  Trends Neurosci       Date:  2021-01-21       Impact factor: 13.837

Review 9.  Retroviral matrix and lipids, the intimate interaction.

Authors:  Elise Hamard-Peron; Delphine Muriaux
Journal:  Retrovirology       Date:  2011-03-07       Impact factor: 4.602

10.  Substitution of the myristoylation signal of human immunodeficiency virus type 1 Pr55Gag with the phospholipase C-delta1 pleckstrin homology domain results in infectious pseudovirion production.

Authors:  Emiko Urano; Toru Aoki; Yuko Futahashi; Tsutomu Murakami; Yuko Morikawa; Naoki Yamamoto; Jun Komano
Journal:  J Gen Virol       Date:  2008-12       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.